assessment of a case of
TRANSCRIPT
-
8/14/2019 Assessment of a Case Of
1/23
Dr.Mohammed AbdallaDr.Mohammed AbdallaObst.Gyn.SpecialistObst.Gyn.Specialist
Egypt, Domiat G. HospitalEgypt, Domiat G. Hospital
ASSESSMENT OF A CASEASSESSMENT OF A CASE
OFOF AMENORRHEAAMENORRHEA
-
8/14/2019 Assessment of a Case Of
2/23
AMENORRHEAAMENORRHEA
Amenorrhea is the absence or abnormalAmenorrhea is the absence or abnormal
cessation of the menses. A patient iscessation of the menses. A patient is
diagnosed with primary amenorrhea if shediagnosed with primary amenorrhea if she
has not reached menarche by age 15.1has not reached menarche by age 15.1
She meets the criteria for secondaryShe meets the criteria for secondary
amenorrhea if established menses haveamenorrhea if established menses have
ceased for longer than 6 monthsceased for longer than 6 months
-
8/14/2019 Assessment of a Case Of
3/23
Etiology of AmenorrheaEtiology of Amenorrhea
PrimaryPrim
aryGonadal failure(43%)Gonadal failure(43%)
Congenital absence of uterus and vagina(15%)Congenital absence of uterus and vagina(15%)Constitutional delay(14%)Constitutional delay(14%)
SecondarySeconda
ryChronic anovulation(39%)Chronic anovulation(39%)
Hypothyroidism / hyperprolactinemia(20%)Hypothyroidism / hyperprolactinemia(20%)Weight loss/anorexia(16%)Weight loss/anorexia(16%)
-
8/14/2019 Assessment of a Case Of
4/23
THE ASSESSMENTTHE ASSESSMENT
-
8/14/2019 Assessment of a Case Of
5/23
Primary amenorrhea
vagina
no yes
congenital uterovaginalcongenital uterovaginal
agenesisagenesis
imperforate hymenimperforate hymencomplete transversecomplete transverse
vaginal septumvaginal septum
Pubic hair
EstrogenizedEstrogenized
breasts havebreasts havedevelopeddeveloped
the (MPA) challengethe (MPA) challenge
abnormal ovariesabnormal ovariesabnormal hormonal stimulation of normal ovaabnormal hormonal stimulation of normal ova
FSH Level
ChromosomeChromosome
AnalysisAnalysis
no
noyes
complete androgencomplete androgen
insensitivityinsensitivity)syndrome )CAIS)syndrome )CAIS
+ -
high low
-
8/14/2019 Assessment of a Case Of
6/23
Secondary AmenorrheaSecondary Amenorrhea
-
8/14/2019 Assessment of a Case Of
7/23
Secondary amenorrhea is the absenceSecondary amenorrhea is the absence
of menstrual periods for 6 months in aof menstrual periods for 6 months in a
woman who had previously beenwoman who had previously been
regular, or for 12 months in a womanregular, or for 12 months in a woman
who had irregular periods.who had irregular periods.
-
8/14/2019 Assessment of a Case Of
8/23
incidenceincidence
1%1% of women of reproductive age.of women of reproductive age.
-
8/14/2019 Assessment of a Case Of
9/23
The most common cause of secondaryThe most common cause of secondary
amenorrhea in reproductive ageamenorrhea in reproductive age
women iswomen is pregnancypregnancy and this shouldand this should
always be excluded by physical examalways be excluded by physical exam
and laboratory testing for theand laboratory testing for the
pregnancy hormone - HCG.pregnancy hormone - HCG.
-
8/14/2019 Assessment of a Case Of
10/23
HistoryHistory
A good history can reveal the etiologicA good history can reveal the etiologicdiagnosis in up to 85% of cases ofdiagnosis in up to 85% of cases of
amenorrhea.amenorrhea.
-
8/14/2019 Assessment of a Case Of
11/23
GalactorrheaGalactorrhea
hot flashes, breast atrophy andhot flashes, breast atrophy anddecreaseddecreased libidolibido
CertainCertainmedicationsmedications
A large amount of weight loss or gainA large amount of weight loss or gain
Anorexia nervosaAnorexia nervosa
Cushing's disease and hypothyroidismCushing's disease and hypothyroidism
.Sheehan's syndrome.Sheehan's syndrome
Asherman's syndromeAsherman's syndrome
Amenorrhea following cervicalAmenorrhea following cervicalconizationconization
Following discontinuation of oral contraceptionFollowing discontinuation of oral contraception
HistoryHistory
-
8/14/2019 Assessment of a Case Of
12/23
Physical examinationPhysical examination
Signs of androgen excessSigns of androgen excess
The breast exam may reveal galactorrheaThe breast exam may reveal galactorrhea
Estrogen deficiency may be suggested onEstrogen deficiency may be suggested on
pelvic exam by a smooth vagina thatpelvic exam by a smooth vagina thatlacks the normal rugae (wrinkles) and alacks the normal rugae (wrinkles) and a
dry endocervix with no mucousdry endocervix with no mucous
-
8/14/2019 Assessment of a Case Of
13/23
what the doctor will dowhat the doctor will do
?next?next
-
8/14/2019 Assessment of a Case Of
14/23
If the history and physicalIf the history and physical
exam are suggestive of aexam are suggestive of a
certain etiologycertain etiology::
for the sake of efficiency and cost-for the sake of efficiency and cost-effectiveness, the workup caneffectiveness, the workup can
sometimes be more directed.sometimes be more directed. ( in 85%( in 85%
of cases .)of cases .)
-
8/14/2019 Assessment of a Case Of
15/23
Some patients will not demonstrate anySome patients will not demonstrate any
obvious etiology for their amenorrheaobvious etiology for their amenorrhea
on history and physical exam. Theseon history and physical exam. These
patients can be worked up in a logicalpatients can be worked up in a logical
manner using a stepwise approach.manner using a stepwise approach.
-
8/14/2019 Assessment of a Case Of
16/23
the first tests to perform after pregnancy isthe first tests to perform after pregnancy is
ruled out are :ruled out are :
a progesterone withdrawal testa progesterone withdrawal test
TSH (thyroid stimulating hormone)TSH (thyroid stimulating hormone)
prolactin level.prolactin level.
-
8/14/2019 Assessment of a Case Of
17/23
Preg.test
TSH ,PROLACTIN,
Prog.challenge test
withdrawal
bleeding
without withdrawal
bleeding
hypoestrogenic compromised.outflow tract
ve.est,progest.+
challenge testve.est,progest-
challenge test.
FSH>30-40Normal FSH
HSG OR hysteroscopy
asherman
2wk
FSH norm.
repeatRepeat+serum
,est.level
PROFhypothalamic-pituitary failure
anovulation
VE-
-
8/14/2019 Assessment of a Case Of
18/23
Ovarian failure )prematureOvarian failure )premature
menopausemenopause))
chromosomal
anomalies autoimmune
disease
If the woman is under
30, a karyotype should
be performed to rule
out any mosaicism
involving a Y
.chromosome
it is prudent to screen
for thyroid, parathyroid,
and adrenal dysfunction
If a Y chromosome is
found the gonads
should be surgically.excised
Laboratory evidence of
autoimmune phenomenon is much
more prevalent than clinically
significant disease
-
8/14/2019 Assessment of a Case Of
19/23
autoimmune related dysfunctionautoimmune related dysfunction
The most common association is with thyroidThe most common association is with thyroid
disease, but the parathyroids and adrenals can alsodisease, but the parathyroids and adrenals can also
be affected.be affected.
Several studies have shown laboratory evidence ofSeveral studies have shown laboratory evidence ofimmune problems in about 15-40% of women withimmune problems in about 15-40% of women with
premature ovarian failure.premature ovarian failure.
In general, ovarian biopsy is not indicated inIn general, ovarian biopsy is not indicated in
patients with premature ovarian failure since nopatients with premature ovarian failure since no
clinically useful information will be obtained.clinically useful information will be obtained.
-
8/14/2019 Assessment of a Case Of
20/23
Hypothalamic-pituitary failureHypothalamic-pituitary failure
Patients who do not bleed after thePatients who do not bleed after the
progestin challenge but do afterprogestin challenge but do after
estrogen/progestin and have normal orestrogen/progestin and have normal or
low FSH and LH levelslow FSH and LH levels
-
8/14/2019 Assessment of a Case Of
21/23
Hypothalamic-pituitary failureHypothalamic-pituitary failure
Some medications (e.g. phenothiazines) as well asSome medications (e.g. phenothiazines) as well asextremes of weight loss, stress or exercise canextremes of weight loss, stress or exercise cancause this type of secondary amenorrhea.cause this type of secondary amenorrhea.
A pituitary or hypothalamic tumor would be a rareA pituitary or hypothalamic tumor would be a rarefinding in these patients who were all screenedfinding in these patients who were all screenedwith prolactin levels at the beginning of thewith prolactin levels at the beginning of thediagnostic evaluation.diagnostic evaluation.
However, if there is no cause apparent from theHowever, if there is no cause apparent from thehistory, it would be prudent to obtain a baselinehistory, it would be prudent to obtain a baselineCT (or MRI) evaluation of the sellar region to ruleCT (or MRI) evaluation of the sellar region to ruleout a space occupying lesion.out a space occupying lesion.
-
8/14/2019 Assessment of a Case Of
22/23
Hypothalamic-pituitary failureHypothalamic-pituitary failure
Patients with normal prolactin levels and normalPatients with normal prolactin levels and normalimaging studies have hypothalamic amenorrhea ofimaging studies have hypothalamic amenorrhea ofuncertain etiology.uncertain etiology.
If the amenorrhea and lack of withdrawal bleedingIf the amenorrhea and lack of withdrawal bleeding
persists, prolactin levels should be measuredpersists, prolactin levels should be measured
annually since a small microadenoma could beannually since a small microadenoma could be
present that is escaping laboratory andpresent that is escaping laboratory andradiographic detection.radiographic detection.
-
8/14/2019 Assessment of a Case Of
23/23
Hypothalamic-pituitary failureHypothalamic-pituitary failure
In this condition, as well as in the otherIn this condition, as well as in the other
hypothalamic amenorrhea situations, the patientshypothalamic amenorrhea situations, the patients
can be significantly hypo estrogenic (a lowcan be significantly hypo estrogenic (a low
estrogen situation similar to menopause). If theestrogen situation similar to menopause). If thestate is persistent, hormone replacement therapystate is persistent, hormone replacement therapy
should be considered for protection againstshould be considered for protection against
osteoporosis. One approach is to get an estradiolosteoporosis. One approach is to get an estradiol
level andlevel and if it is less than 30 pg/ml,if it is less than 30 pg/ml, counsel thecounsel thepatient that hormonal replacement therapy ispatient that hormonal replacement therapy is
indicatedindicated